Target intelligence / Profile preview

Apicoplast DNA polymerase (apPol) (apPol)

Target
apPol
Molecular classification
Enzyme, DNA polymerase, Transferase
01

Overview

Apicoplast DNA polymerase (apPol) is the essential enzyme responsible for the replication and repair of the 35-kb circular genome found within the apicoplast of Plasmodium parasites. The apicoplast is a vestigial, non-photosynthetic plastid derived from an ancient endosymbiotic event, and it is vital for the parasite’s survival, primarily as the site of isoprenoid precursor biosynthesis. In species like Plasmodium falciparum, the polymerase is often encoded as part of a multifunctional polyprotein called Pfprex (Plastid replication-repair enzyme), which contains primase, helicase, and polymerase domains. As an A-family DNA polymerase with prokaryotic lineage, apPol is structurally distinct from human nuclear and mitochondrial polymerases, providing a unique opportunity for highly selective antimalarial drug development. Inhibition of apicoplast DNA synthesis—whether by targeting apPol directly or associated proteins like DNA gyrase—typically results in a characteristic 'delayed death' phenotype. This phenomenon involves the parasite surviving the initial drug exposure but failing to survive in the subsequent generation due to the loss of functional apicoplasts in daughter cells. This target is particularly valued for its potential to combat multidrug-resistant malaria when used in combination therapies.

Other names
Plasmodium apicoplast DNA synthesisApicoplast DNA replicationPlastid replication-repair enzymePfprexApicoplast replisomeApicoplast DNA polymerase I
02

Mechanism of action

Inhibition of DNA synthesis within the apicoplast prevents the replication and inheritance of the organelle's genome, leading to the loss of the essential apicoplast and subsequent parasite death, typically manifesting as a 'delayed death' phenotype.

03

Biological functions

DNA replicationDNA repairOrganelle maintenanceGenome stability
04

Disease associations

Infection
05

Safety considerations

Potential off-target inhibition of host mitochondrial DNA polymerase gamma (Pol gamma)Slow therapeutic onset (delayed death) necessitating combination with rapid-acting antimalarialsDevelopment of drug resistance via mutations in the polymerase or gyrase genes
06

Interacting drugs

Ciprofloxacin

4 more in the full profile.

07

Biomarkers

Apicoplast genome copy number (qPCR)Isopentenyl pyrophosphate (IPP) rescueDelayed death phenotype in vitro

Beyond the preview

Go deeper on Apicoplast DNA polymerase (apPol) (apPol).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apicoplast DNA polymerase (apPol) (apPol).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call